for the Digiday Programmatic Marketing Summit, May 6-8 in Palm Springs.
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
The promise and threat of AI, as understood through the eyes of Possible
Nielsen’s Peter Naylor, Multilocal’s Fern Potter and Crossmedia’s Kamran Asghar shared their learnings and teachings coming out of the Possible conference in Miami.
‘The bridge between intuition and ROI’: The M&A race to own advertising’s last unmeasured lever
The ad industry’s hottest M&A target isn’t what you think.
CMOs continue their uphill climb in the eyes of their CEOs: Boathouse study
Where 68% of CMOs are seen as actively contributing to strategy and strategic decisions, only 8% are perceived as actually leading it.